Comprehensive transcriptome profiling between balding and non-balding scalp of female pattern hair loss in Asian

• Published in: Archives of dermatological research 2024-06, Vol.316 (7), p.360, Article 360
• Main Authors: Kim, Soon Re, Kim, Yun Ji, Kim, Ju-Hee, Kim, Su Na, Park, Won Serk, Kim, Se Hwan, Chung, Juhyun, Choi, Mi soo, Kim, MyungHwa, Park, Byung Cheol
• Format: Article
• Language: English
• Subjects: Adult; Alopecia - genetics; Alopecia - pathology; Asian People - genetics; Biomarkers; CXCR3 protein; Dermatology; Female; Follicles; Gene expression; Gene Expression Profiling; Genetic analysis; Hair; Hair Follicle - metabolism; Hair Follicle - pathology; Hair loss; High-Throughput Nucleotide Sequencing; Humans; Immunohistochemistry; Medicine; Medicine & Public Health; Membrane Proteins - genetics; Membrane Proteins - metabolism; Middle Aged; Next-generation sequencing; Proto-Oncogene Proteins; Scalp - pathology; Study Protocol; Therapeutic targets; Transcriptome; Transcriptomes; Young Adult
• ISSN: 1432-069X; 0340-3696; 1432-069X
• DOI: 10.1007/s00403-024-03114-w

While many gene expression studies have focused on male pattern baldness (MPB), few studies have investigated the genetic differences between bald and non-bald hair follicles in female pattern hair loss (FPHL). This study aimed to identify molecular biomarkers associated with FPHL through genetic analysis of paired bald and non-bald hair follicles from 18 FPHL patients, using next-generation sequencing (NGS) techniques. RNA transcriptome analysis was performed to identify differentially expressed genes (DEGs) between bald and non-bald hair follicles in FPHL. The DEGs were validated using real-time PCR, and protein expression was confirmed through immunohistochemistry and western blot analysis. Our findings suggest that HOXB13, SFRP2, PTGDS, CXCR3, SFRP4, SOD3, and DCN are significantly upregulated in bald hair follicles compared to non-bald hair follicles in FPHL. SFRP2 and PTGDS were found to be consistently highly expressed in bald hair follicles in all 18 samples. Additionally, elevated protein levels of SFRP2 and PTGDS were confirmed through western blot and immunohistochemical analysis. Our study identified SFRP2 and PTGDS as potential biomarkers for FPHL and suggests that they may play a role in inducing hair loss in this condition. These findings provide a foundation for further research on the pathogenesis of FPHL and potential therapeutic targets.